# Propagation ANalysis for Arrhythmogenic Conduction Elimination to Prevent Atrial Flutter and Fibrillation (PANACEA-AF)

> **NCT03737838** · — · COMPLETED · sponsor: **University of Chicago** · enrollment: 29 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Atrial fibrillation ablation

## Key facts

- **NCT ID:** NCT03737838
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-31
- **Primary completion:** 2021-02-24
- **Final completion:** 2021-02-24
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2024-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03737838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03737838, "Propagation ANalysis for Arrhythmogenic Conduction Elimination to Prevent Atrial Flutter and Fibrillation (PANACEA-AF)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03737838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*